Form 4: Fortrea Director Neupert Receives RSU Grant

Director Peter M. Neupert was granted 12,852 restricted stock units by Fortrea Holdings Inc. on June 10, 2026.

Summary

• Director Peter M. Neupert received an award of 12,852 Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of Fortrea Holdings Inc. common stock upon settlement.
• The award is subject to a vesting period of twelve months from the grant date of June 10, 2026.
• Vesting is contingent upon the director's continued service to the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon the eventual settlement of the RSUs.

Risks

• Vesting is dependent on continued service, creating a retention dependency.

Future Outlook

The RSUs will vest in their entirety on June 10, 2027, provided the director remains in service to the company.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the clinical research and pharmaceutical services industry to ensure alignment with long-term performance goals.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices among mid-to-large cap publicly traded companies.
• The one-year cliff vesting schedule is a common retention mechanism for board members in the life sciences sector.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual conversion of RSUs to common stock.

Next Steps

• Vesting of the RSU award on June 10, 2027.

Key Dates

Keywords

Fortrea Holdings, FTRE, Form 4, Insider Trading, Restricted Stock Units, Director Compensation